John  Landry net worth and biography

John Landry Biography and Net Worth

CFO of Vapotherm
John Landry has served as Senior Vice President and Chief Financial Officer, Secretary and Treasurer since August 2012. Prior to joining Vapotherm, he held a number of leadership roles at Salient from 2004 to 2011, including VP Accounting & Controller and VP Global Business Development. Mr. Landry also served as Director of International Marketing at Medtronic Advanced Energy from 2011 to 2012, which acquired Salient in August 2011. Prior to his time at Salient, he served in various financial leadership roles at Bottomline Technologies from 2000 to 2004, Hussey Seating Company from 1997 to 2000 and Coopers & Lybrand LLP from 1994 to 2000. Mr. Landry graduated summa cum laude from Bentley College with a BS in Accountancy and is a certified public accountant.

What is John Landry's net worth?

The estimated net worth of John Landry is at least $103,452.58 as of February 10th, 2023. Mr. Landry owns 47,674 shares of Vapotherm stock worth more than $103,453 as of November 23rd. This net worth estimate does not reflect any other assets that Mr. Landry may own. Additionally, Mr. Landry receives an annual salary of $552,050.00 as CFO at Vapotherm. Learn More about John Landry's net worth.

How old is John Landry?

Mr. Landry is currently 51 years old. There are 5 older executives and no younger executives at Vapotherm. The oldest executive at Vapotherm is Mr. James A. Lightman, Senior VP, General Counsel & Secretary, who is 66 years old. Learn More on John Landry's age.

What is John Landry's salary?

As the CFO of Vapotherm, Inc., Mr. Landry earns $552,050.00 per year. The highest earning executive at Vapotherm is Mr. Joseph F. Army CPA, CEO, President & Director, who commands a salary of $776,250.00 per year. Learn More on John Landry's salary.

How do I contact John Landry?

The corporate mailing address for Mr. Landry and other Vapotherm executives is 100 DOMAIN DRIVE, EXETER NH, 03833. Vapotherm can also be reached via phone at (866) 410-9986 and via email at [email protected]. Learn More on John Landry's contact information.

Has John Landry been buying or selling shares of Vapotherm?

John Landry has not been actively trading shares of Vapotherm during the last ninety days. Most recently, on Friday, February 10th, John Landry bought 8,928 shares of Vapotherm stock. The stock was acquired at an average cost of $8.40 per share, with a total value of $74,995.20. Following the completion of the transaction, the chief financial officer now directly owns 47,674 shares of the company's stock, valued at $400,461.60. Learn More on John Landry's trading history.

Who are Vapotherm's active insiders?

Vapotherm's insider roster includes Joel Dube (CAO), John Landry (CFO), James Liken (Director), Gregoire Ramade (SVP), and Thomas Smith (Insider). Learn More on Vapotherm's active insiders.

John Landry Insider Trading History at Vapotherm

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/10/2023Buy8,928$8.40$74,995.2047,674View SEC Filing Icon  
11/28/2022Buy16,875$6.24$105,300.0037,884View SEC Filing Icon  
5/24/2022Buy625$23.20$14,500.0016,009View SEC Filing Icon  
8/27/2021Sell1,399$222.00$310,578.00View SEC Filing Icon  
8/9/2021Sell1,100$220.16$242,176.00View SEC Filing Icon  
9/5/2019Buy375$82.72$31,020.0012,212View SEC Filing Icon  
See Full Table

John Landry Buying and Selling Activity at Vapotherm

This chart shows John Landry's buying and selling at Vapotherm by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vapotherm Company Overview

Vapotherm logo
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Read More

Today's Range

Now: $2.17
Low: $2.16
High: $2.17

50 Day Range

MA: $2.16
Low: $2.13
High: $2.18

2 Week Range

Now: $2.17
Low: $0.70
High: $3.44

Volume

51,500 shs

Average Volume

N/A

Market Capitalization

$13.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A